{"id":20910,"date":"2021-09-23T05:07:15","date_gmt":"2021-09-23T05:07:15","guid":{"rendered":"https:\/\/lrh.health.gov.lk\/?page_id=20910"},"modified":"2021-09-29T08:58:29","modified_gmt":"2021-09-29T08:58:29","slug":"pfizer-indication","status":"publish","type":"page","link":"https:\/\/lrh.health.gov.lk\/pfizer-indication\/","title":{"rendered":"Pfizer Vaccination Eligibility Criteria"},"content":{"rendered":"<p>Pfizer vaccination is available for children between 12-19 years with the following co-morbidities ONLY. (Guideline from Sri Lanka College of Paediatricians)<\/p>\n<div dir=\"ltr\">\u00a0<b><span lang=\"EN-GB\">Indications for immunization against COVID-19 with Pfizer vaccine for children aged 12 years and above at the first phase: Underlying health conditions<\/span><\/b><\/div>\n<div dir=\"ltr\">\n<div>\n<p><span lang=\"EN-GB\">1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Primary immune deficiency disorders<\/span><\/p>\n<p><span lang=\"EN-GB\">2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Acquired immune suppression due to disease or treatment:<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Haematological malignancies, including leukaemia and lymphoma<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Any other malignancy on radiotherapy or chemotherapy<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">On biological therapy<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">On high or moderate doses of corticosteroids<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">On any other immune modulating or suppressant drug like methotrexate, azathioprine, MMF, tacrolimus, cyclophosphamide<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Any transplant recipient<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Any condition which requires a long-term immunosuppressive treatments<\/span><\/p>\n<p><span lang=\"EN-GB\">3.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Haematological conditions or other causes leading to asplenia or splenic dysfunction:<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Thalassemia major and intermedius,\u00a0<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Hereditary spherocytosis<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Sickle cell disease<\/span><\/p>\n<p><span lang=\"EN-GB\">4.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Endocrine disorders:<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Diabetes mellitus<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Addison\u2019s disease<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Congenital Adrenal Hyperplasia\u00a0 \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Hypopituitary syndrome<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Other significant hormonal dysfunction<\/span><\/p>\n<p><span lang=\"EN-GB\">5.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">\u00a0Chronic neuro-disability:<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Cerebral palsy<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Autism<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Epilepsy,<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Neuro-degenerative diseases<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Neuro-muscular disorders<\/span><\/p>\n<p><span lang=\"EN-GB\">6.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Learning disabilities<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Down syndrome<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Severe or profound and multiple learning disabilities due to any aetiology<\/span><\/p>\n<p><span lang=\"EN-GB\">7.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Any other significant genetic and\/or metabolic abnormalities that affect a number of systems<\/span><\/p>\n<p><span lang=\"EN-GB\">8.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">\u00a0Chronic heart disorders<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Unrepaired congenital heart diseases<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Repaired heart diseases with significant residual diseases or shunts<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Haemodynamically significant acquired heart diseases<\/span><\/p>\n<p><span lang=\"EN-GB\">9.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Chronic respiratory disorders<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Poorly controlled asthma which requires long term oral steroids or a history of severe asthma which required an ICU care\u00a0<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Cystic fibrosis<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Bronchopulmonary dysplasia<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Interstitial lung diseases<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Significant bronchiectasis due to any aetiology<\/span><\/p>\n<p><span lang=\"EN-GB\">\u00b7\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Pulmonary hypertension<\/span><\/p>\n<p><span lang=\"EN-GB\">10.\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Chronic kidney diseases and nephrotic syndrome on regular follow up<\/span><\/p>\n<p><span lang=\"EN-GB\">11.\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Chronic liver diseases<\/span><\/p>\n<p><span lang=\"EN-GB\">12.\u00a0\u00a0\u00a0<\/span><span lang=\"EN-GB\">Chronic gastrointestinal disorders including inflammatory bowel disease\u00a0<\/span><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Pfizer vaccination is available for children between 12-19 years with the following co-morbidities ONLY. (Guideline from Sri Lanka College of Paediatricians) \u00a0Indications for immunization against COVID-19 with Pfizer vaccine for children aged 12 years and above at the first phase: Underlying health conditions 1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Primary immune deficiency disorders 2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Acquired immune suppression due to disease or treatment:&#8230;<\/p>\n","protected":false},"author":8,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.0 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Pfizer Vaccination Eligibility Criteria - Lady Ridgeway Hospital for Children<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/lrh.health.gov.lk\/pfizer-indication\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pfizer Vaccination Eligibility Criteria - Lady Ridgeway Hospital for Children\" \/>\n<meta property=\"og:description\" content=\"Pfizer vaccination is available for children between 12-19 years with the following co-morbidities ONLY. (Guideline from Sri Lanka College of Paediatricians) \u00a0Indications for immunization against COVID-19 with Pfizer vaccine for children aged 12 years and above at the first phase: Underlying health conditions 1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Primary immune deficiency disorders 2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Acquired immune suppression due to disease or treatment:...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/lrh.health.gov.lk\/pfizer-indication\/\" \/>\n<meta property=\"og:site_name\" content=\"Lady Ridgeway Hospital for Children\" \/>\n<meta property=\"article:modified_time\" content=\"2021-09-29T08:58:29+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/lrh.health.gov.lk\/pfizer-indication\/\",\"url\":\"https:\/\/lrh.health.gov.lk\/pfizer-indication\/\",\"name\":\"Pfizer Vaccination Eligibility Criteria - Lady Ridgeway Hospital for Children\",\"isPartOf\":{\"@id\":\"https:\/\/lrh.health.gov.lk\/#website\"},\"datePublished\":\"2021-09-23T05:07:15+00:00\",\"dateModified\":\"2021-09-29T08:58:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/lrh.health.gov.lk\/pfizer-indication\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/lrh.health.gov.lk\/pfizer-indication\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/lrh.health.gov.lk\/pfizer-indication\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/lrh.health.gov.lk\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pfizer Vaccination Eligibility Criteria\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/lrh.health.gov.lk\/#website\",\"url\":\"https:\/\/lrh.health.gov.lk\/\",\"name\":\"Lady Ridgeway Hospital for Children\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/lrh.health.gov.lk\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pfizer Vaccination Eligibility Criteria - Lady Ridgeway Hospital for Children","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/lrh.health.gov.lk\/pfizer-indication\/","og_locale":"en_US","og_type":"article","og_title":"Pfizer Vaccination Eligibility Criteria - Lady Ridgeway Hospital for Children","og_description":"Pfizer vaccination is available for children between 12-19 years with the following co-morbidities ONLY. (Guideline from Sri Lanka College of Paediatricians) \u00a0Indications for immunization against COVID-19 with Pfizer vaccine for children aged 12 years and above at the first phase: Underlying health conditions 1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Primary immune deficiency disorders 2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Acquired immune suppression due to disease or treatment:...","og_url":"https:\/\/lrh.health.gov.lk\/pfizer-indication\/","og_site_name":"Lady Ridgeway Hospital for Children","article_modified_time":"2021-09-29T08:58:29+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/lrh.health.gov.lk\/pfizer-indication\/","url":"https:\/\/lrh.health.gov.lk\/pfizer-indication\/","name":"Pfizer Vaccination Eligibility Criteria - Lady Ridgeway Hospital for Children","isPartOf":{"@id":"https:\/\/lrh.health.gov.lk\/#website"},"datePublished":"2021-09-23T05:07:15+00:00","dateModified":"2021-09-29T08:58:29+00:00","breadcrumb":{"@id":"https:\/\/lrh.health.gov.lk\/pfizer-indication\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/lrh.health.gov.lk\/pfizer-indication\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/lrh.health.gov.lk\/pfizer-indication\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/lrh.health.gov.lk\/"},{"@type":"ListItem","position":2,"name":"Pfizer Vaccination Eligibility Criteria"}]},{"@type":"WebSite","@id":"https:\/\/lrh.health.gov.lk\/#website","url":"https:\/\/lrh.health.gov.lk\/","name":"Lady Ridgeway Hospital for Children","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lrh.health.gov.lk\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/lrh.health.gov.lk\/wp-json\/wp\/v2\/pages\/20910"}],"collection":[{"href":"https:\/\/lrh.health.gov.lk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/lrh.health.gov.lk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/lrh.health.gov.lk\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/lrh.health.gov.lk\/wp-json\/wp\/v2\/comments?post=20910"}],"version-history":[{"count":0,"href":"https:\/\/lrh.health.gov.lk\/wp-json\/wp\/v2\/pages\/20910\/revisions"}],"wp:attachment":[{"href":"https:\/\/lrh.health.gov.lk\/wp-json\/wp\/v2\/media?parent=20910"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}